Amicus Therapeutics received drug approvals in multiple countries, including the US, Japan, Canada, and Switzerland.
3 reports, 1 independent
Updated Jul 17
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Amicus Therapeutics received drug approvals in multiple countries, including the US, Japan, Canada, and Switzerland.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Amicus Therapeutics received MHLW approval in Japan for Pombiliti + Opfolda treatment for LOPD.Sub-event
Amicus Therapeutics secured international drug approvals across several major markets.1 source
Keep exploring
The entities involved
-
Amicus Therapeutics
company in Cranbury, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- Insider MonkeyAmicus (FOLD) Gets Japan Approval for Pombiliti + Opfolda Amicus Therapeutics, Inc. (NASDAQ:FOLD) is one of the 10 Best Small-Cap Stocks to Buy According to Billionaires. On June 25, Amicus Therapeut
- Unknown outlet
- Unknown outlet